Healthy Skepticism Library item: 15069

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Glaxo Warns of a Charge, Hints at Pact
The Wall Street Journal 2008 Jan 30
http://online.wsj.com/article/SB123327051846730799.html

Abstract:

GlaxoSmithKline PLC warned that its 2008 earnings will be hit by a $400 million legal charge, in a sign that the pharmaceutical company could be approaching a settlement in a five-year-old federal investigation into marketing of antidepressants and other drugs.

Glaxo said the charge was related to the ongoing investigation, which is looking at “marketing and promotional practices for several products for the period 1997 to 2004.” Those products include the antidepressants Wellbutrin SR, according to the company; Paxil is another, according to people familiar with the matter.